Botulinum Toxin in Movement Disorders: An Update.

Botulinum Toxin in Movement Disorders: An Update.
Related ArticlesBotulinum Toxin in Movement Disorders: An Update. Toxins (Basel). 2021 Jan 08;13(1): Authors: Anandan C, Jankovic J Abstract Since its initial approval in 1989 by the US Food and Drug Administration for the treatment of blepharospasm and other facial spasms, botulinum toxin (BoNT) has evolved into a therapeutic modality for a variety of neurological and non-neurological disorders. With respect ... read more
Source: PubMedPublished on 2021-01-13